Work

Treatment preferences of patients with recurrent or metastatic cervical cancer: a discrete choice experiment in the US

Year: 2025

Type: article

Abstract: Objective: This study assessed treatment preferences of patients with recurrent/metastatic cervical cancer, a disease with poor prognosis. Methods: A survey with two discrete choice experiments was completed by 150 patients with recurrent/metastatic cervical cancer in the US. Discrete choice experiment 1 included treatment attributes, and discrete choice experiment 2 included risk mitigation plan attributes. Results: Participants valued 12-month overall survival rate as the most important attribute, followed by disease control rate; both efficacy attributes were rated as more important than the risk of side effects such as peripheral neuropathy and corneal side effects. Participants' willingness to accept a treatment profile requiring a risk mitigation plan was influenced by the number of clinic visits and out-of-pocket costs. Conclusions: Patients with recurrent/metastatic cervical cancer prioritize overall survival and disease control rate as the most important attributes. These findings can be used to inform shared decision-making and treatment discussions among patients, clinicians, and the care team.

Source: Gynecologic Oncology Reports

DOI: 10.1016/j.gore.2025.101947